Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis

Journal of Human Genetics

Volumn 58, Issue 5, 2013, Pages 298-303

  Jang, Mi Ae ^a   Kim, Su Young ^a   Jeong, Byeong Ho ^a   Park, Hye Yun ^a   Jeon, Kyeongman ^a   Kim, Jong Won ^a   Ki, Chang Seok ^a   Koh, Won Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CFTR; cystic fibrosis; Koreans; mutation; nontuberculous mycobacteria

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ARTICLE; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MUTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; REPUBLIC OF KOREA; YOUNG ADULT;

CORYNEBACTERINEAE;

EID: 84878569233     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.19     Document Type: Article

References (29)

1. Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175, 367-416 (2007).
2. Daley, C. L. & Griffith, D. E. Pulmonary non-tuberculous mycobacterial infections. Int. J. Tuberc. Lung Dis. 14, 665-671 (2010).
3. Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A. et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am. J. Respir. Crit. Care Med. 182, 970-976 (2010).
4. Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M. & Prevots, D. R. Prevalence of nontuberculous mycobacterial lung disease in USA Medicare beneficiaries. Am. J. Respir. Crit. Care Med. 185, 881-886 (2012).
5. Hayashi, M., Takayanagi, N., Kanauchi, T., Miyahara, Y., Yanagisawa, T. & Sugita, Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am. J. Respir. Crit. Care Med. 185, 575-583 (2012).
6. Koh, W. J., Jeong, B. H., Jeon, K., Lee, N. Y., Lee, K. S., Woo, S. Y. et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease. Chest 142, 1482-1488 (2012).
7. Jarand, J., Levin, A., Zhang, L., Huitt, G., Mitchell, J. D. & Daley, C. L. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin. Infect. Dis. 52, 565-571 (2011).
8. Koh, W. J., Jeon, K., Lee, N. Y., Kim, B. J., Kook, Y. H., Lee, S. H. et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am. J. Respir. Crit. Care Med. 183, 405-410 (2011).
9. Guide, S. V. & Holland, S. M. Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect. Dis. Clin. North Am. 16, 163-186 (2002).
10. Sexton, P. & Harrison, A. C. Susceptibility to nontuberculous mycobacterial lung disease. Eur. Respir. J. 31, 1322-1333 (2008).
11. Kim, R. D., Greenberg, D. E., Ehrmantraut, M. E., Guide, S. V., Ding, L., Shea, Y. et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 178, 1066-1074 (2008).
12. Lobo, J., Rojas-Balcazar, J. M. & Noone, P. G. Recent advances in cystic fibrosis. Clin. Chest Med. 33, 307-328 (2012).
13. Olivier, K. N., Weber, D. J., Wallace, R. J. Jr., Faiz, A. R., Lee, J. H., Zhang, Y. et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167, 828-834 (2003).
14. Rodman, D. M., Polis, J. M., Heltshe, S. L., Sontag, M. K., Chacon, C., Rodman, R. V. et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am. J. Respir. Crit. Care Med. 171, 621-626 (2005).
15. Ziedalski, T. M., Kao, P. N., Henig, N. R., Jacobs, S. S. & Ruoss, S. J. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 130, 995-1002 (2006).
16. Yamashiro, Y., Shimizu, T., Oguchi, S., Shioya, T., Nagata, S. & Ohtsuka, Y. The estimated incidence of cystic fibrosis in Japan. J. Pediatr. Gastroenterol. Nutr. 24, 544-547 (1997).
17. Jung, H., Ki, C. S., Koh, W. J., Ahn, K. M., Lee, S. I., Kim, J. H. et al. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis. Korean J. Lab. Med. 31, 219-224 (2011).
18. Mai, H. N., Hijikata, M., Inoue, Y., Suzuki, K., Sakatani, M., Okada, M. et al. Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene. Int. J. Tuberc. Lung Dis. 11, 808-813 (2007).
19. Koh, W. J., Lee, K. S., Kwon, O. J., Jeong, Y. J., Kwak, S. H. & Kim, T. S. Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 235, 282-288 (2005).
20. Song, J. W., Koh, W. J., Lee, K. S., Lee, J. Y., Chung, M. J., Kim, T. S. et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am. J. Roentgenol. 191, 1070 (2008).
21. Guo, S. W. & Thompson, E. A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48, 361-372 (1992).
22. Lin, S., Cutler, D. J., Zwick, M. E. & Chakravarti, A. Haplotype inference in random population samples. Am. J. Hum. Genet. 71, 1129-1137 (2002).
23. Watson, M. S., Cutting, G. R., Desnick, R. J., Driscoll, D. A., Klinger, K., Mennuti, M. et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet. Med. 6, 387-391 (2004).
24. Lee, J. H., Choi, J. H., Namkung, W., Hanrahan, J. W., Chang, J., Song, S. Y. et al. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum. Mol. Genet. 12, 2321-2332 (2003).
25. Ngiam, N. S., Chong, S. S., Shek, L. P., Goh, D. L., Ong, K. C., Chng, S. Y. et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: a pilot study. J. Cyst. Fibros. 5, 159-164 (2006).
26. Anzai, C., Morokawa, N., Okada, H., Kamidono, S., Eto, Y. & Yoshimura, K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J. Cyst. Fibros. 2, 14-18 (2003).
27. Lee, K. H., Ryu, J. K., Yoon, W. J., Lee, J. K., Kim, Y. T. & Yoon, Y. B.Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig. Dis. Sci. 50, 1852-1856 (2005).
28. Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A. et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Invest. 101, 487-496 (1998).
29. Ghanem, N., Costes, B., Girodon, E., Martin, J., Fanen, P. & Goossens, M. Identification of eight mutations and three sequence variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 21, 434-436 (1994).